Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Methotrexate Plus Triple Therapy for Rheumatoid Arthritis

Evidence-Based Comparison of Combination Therapies

  • Methotrexate is conditionally recommended over leflunomide for patients with rheumatoid arthritis due to its greater dosing flexibility, lower cost, and established efficacy as an anchor drug in combination regimens, according to the American College of Rheumatology 1, 2
  • The American College of Rheumatology (ACR) 2021 guidelines specifically note that methotrexate is preferred over leflunomide because of these advantages 3

Safety Considerations

  • Leflunomide has a less favorable safety profile compared to hydroxychloroquine, which is conditionally recommended over other csDMARDs because it is better tolerated, as stated by the American College of Rheumatology 3
  • Hydroxychloroquine has a more favorable risk profile in patients with RA, making it a valuable component of triple therapy, according to the American College of Rheumatology 3

Treatment Algorithm for Combination Therapy Selection

  • The first-line approach for patients with rheumatoid arthritis is to start with methotrexate monotherapy with rapid dose escalation to 15-25mg weekly within 4-6 weeks, as recommended by the American College of Rheumatology 2
  • Methotrexate should be optimized to 15-25mg weekly (oral or subcutaneous) for patients with rheumatoid arthritis, according to the American College of Rheumatology 2

Important Clinical Considerations

  • Always supplement methotrexate with folic acid to reduce side effects regardless of which combination is chosen, as recommended by the American College of Rheumatology 4

Common Pitfalls to Avoid

  • Failing to optimize methotrexate dosing before adding other DMARDs can lead to inadequate treatment, and it is essential to ensure adequate dose and duration of methotrexate trial, as stated by the American College of Rheumatology 2
  • Neglecting regular monitoring of disease activity and drug toxicity can lead to adverse effects, and it is crucial to check liver function, complete blood count, and renal function regularly, according to the American College of Rheumatology 4
  • Patient education regarding the different side effect profiles of each medication combination is essential to ensure safe and effective treatment, as recommended by the American College of Rheumatology 3